BIOTRONIK - SaFety and Performance Registry for an Allcomers Patient Population With the SiroLimus Eluting Orsiro Stent Within Daily Clinical Practice in Small Vessels - Portugal Registry
Phase of Trial: Phase IV
Latest Information Update: 15 Jul 2019
Price : $35 *
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms BIOFLOW-SV
- Sponsors BIOTRONIK
- 10 Jul 2019 Planned End Date changed from 1 May 2020 to 1 Dec 2020.
- 10 Jul 2019 Planned primary completion date changed from 1 May 2019 to 1 Dec 2019.
- 02 Aug 2018 New trial record